Last reviewed · How we verify

NCT05532839

Self-paced High-intensity Interval Training and Moderate Intensity Continuous Training in Young Adults

Completed NA Last updated 28 November 2022
What this trial tests

NA trial testing High intensity interval training in Psychophysiologic Reaction in 26 participants. Completed in 17 September 2022.

Timeline
17 July 2022
Primary endpoint
17 September 2022
17 September 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date17 July 2022
Primary completion17 September 2022
Estimated completion17 September 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 16 to 35, any sex, with Psychophysiologic Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study will be randomized clinical trial. Data will be collected from non probability convenient sampling technique. Total 26 participants from Pakistan Sports Board will be selected and randomly allocated in two different groups i.e. Group A and Group B. Group A will be given high intensity interval training and Group B will be on moderate intensity continuous training. Statistical package for the social sciences will be used to analyze the results by using parametric test after confirming normality of data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity interval training

Trials testing the same drug.

Other recruiting trials for Psychophysiologic Reaction

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05532839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing